elcatonin

Subscribe to Selected New Research on elcatonin

49 relevant articles (5 outcomes, 5 trials/studies) found for this Bio-Agent

Description: synthetic S-S bond between 1-7 amino acids displaced by C-C bond; deamino dicarba analog of eel calcitonin; has been given orphan drug approval for intrathecal treatment of intractable pain

Also Known As:

1,7-Asu-calcitonin; Alcala brand of elcatonin; CEPA brand of elcatonin; Cantabria brand of elcatonin; Carbicalcin; Diatin; Elactonina Ur; Elcatonina CEPA; Ferrer brand of elcatonin; L-aminosuberylcalcitonin; avicatonin; calcitonin, Asu(1,7)-; calcitonin, aminosuberine(1,7)-; calcitonin, eel, Asu(1,7)-; carbocalcitonin; 1,7-Dicarbacalcitonin, 1-butanoic acid-26-L-aspartic acid-27-L-valine-29-L-alanine-

Relationship Network

Bio-Agent Context: Research Results

Hormones, Hormone Substitutes, and Hormone Antagonists

Hormones: 46253

Peptide Hormones: 377

Calcitonin: 4159

elcatonin: 49

Amino Acids, Peptides, and Proteins

Proteins: 58433

Nerve Tissue Proteins: 2

Peptide Hormones: 377

Calcitonin: 4159

elcatonin: 49

Experts

1.	Miyakoshi, Naohisa: 1 article (01/2006)
2.	Itoi, Eiji: 1 article (01/2006)
3.	Minato, Takashi: 1 article (01/2006)
4.	Ando, Shigeru: 1 article (01/2006)
5.	Shimada, Yoichi: 1 article (01/2006)
6.	Iwamoto, Jun: 1 article (01/2002)
7.	Uzawa, Mitsuyoshi: 1 article (01/2002)
8.	Ichimura, Shoichi: 1 article (01/2002)
9.	Takeda, Tsuyoshi: 1 article (01/2002)
10.	Fujii, Y: 1 article (04/2000)

Related Diseases

1.	Neoplasms (Cancer) 04/01/1995 - "The effect of daily administration of elcatonin was further studied in the FA-6 tumor-bearing mice: 5-Day daily administration of elcatonin was not accompanied by reduction in its hypocalcemic effect. " 04/01/1995 - "The effect reached peaks at 2 hr after its administration, and it was no longer detected at 24 hr. The dose-dependent effects of a single administration of elcatonin were studied in the FA-6 tumor-bearing mice: the hypocalcemic effect of elcatonin at 1-2 hr after administration was dose-relatedly augmented. " 09/01/1987 - "Forty-three cases of metastatic bone tumor were treated with Elcatonin. " 09/01/1987 - "These data indicate that Elcatonin is effective for achieving pain relief and in improving the state of invaded bones when administered in combination with conventional treatment modalities for patients with metastatic bone tumors." 02/01/1985 - "Twenty cases of metastatic bone tumors were treated with Elcatonin together with irradiation, achieving pain relief in 47.3% of cases, improved bone scintigrams in 16.7% of cases and radiographic improvement of invaded bone in 7.7% of cases. " Order ALL the reference details at left...
2.	Pain (Aches) 01/01/1996 - "Carbocalcitonin spray administered for 12 months at a daily dosage of 80 U MRC according to five schedules has been tested on 150 normal spontaneous postmenopausal women for its influence on bone mineral density (BMD), bone metabolism and osteoarticular pain. " 09/01/1987 - "These data indicate that Elcatonin is effective for achieving pain relief and in improving the state of invaded bones when administered in combination with conventional treatment modalities for patients with metastatic bone tumors." 02/01/1985 - "Twenty cases of metastatic bone tumors were treated with Elcatonin together with irradiation, achieving pain relief in 47.3% of cases, improved bone scintigrams in 16.7% of cases and radiographic improvement of invaded bone in 7.7% of cases. " 06/01/2009 - "The antiresorptive drug elcatonin (ECT) is known to relieve pain in postmenopausal women with osteoporosis. " 04/01/2000 - "Effect of avicatonin (chicken carbocalcitonin) on galvanic skin response: a randomized, prospective, double-blind, controlled study for an objective assessment of pain." Order ALL the reference details at left...
3.	Osteoporosis 09/01/1993 - "The efficacy of percutaneous elcatonin (EC), a hypocalcemic peptide, in the treatment of experimental osteoporosis in rats was evaluated in vivo. " 03/01/1993 - "In recent years, the synthetic analogue elcatonin has been used successfully in the treatment of osteoporosis. " 06/01/1987 - "Fifteen patients suffering from osteoporosis of different aetiology and receiving long-term carbocalcitonin treatment were studied in order to evaluate the tolerance of the drug. " 06/01/2009 - "The antiresorptive drug elcatonin (ECT) is known to relieve pain in postmenopausal women with osteoporosis. " 06/01/1996 - "Elcatonin, used for treatment of hypercalcaemia, Paget's disease and osteoporosis, causes flushing of the face and hands. " Order ALL the reference details at left...
4.	Rheumatoid Arthritis 04/01/1994 - "OBJECTIVES--Elcatonin (eCT), an eel calcitonin derivative, is shown to considerably improve the clinical signs and symptoms, as well as laboratory data, in patients with rheumatoid arthritis (RA). " 09/01/1993 - "To clarify the reason for the therapeutic efficacy of Elcatonin (eCT), an eel calcitonin derivative, in rheumatoid arthritis (RA), we studied the effect of eCT on the extracellular (EC) release and intracellular (IC) production of interleukin-1 (IL-1) by peripheral blood monocytes from patients with RA. " Order ALL the reference details at left...
5.	Atrophy 04/01/1988 - "Radionuclide study for assessing the effect of carbocalcitonin on Sudeck's atrophy of the foot." 02/01/1987 - "Carbocalcitonin treatment in Sudeck's atrophy." 07/31/1984 - "Carbocalcitonin was also employed in conditions characterised by a high bone metabolism turnover such as Paget's disease, Sudeck's atrophy and immobilisation osteoporosis. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Calcitonin (Calcitonin, Eel)
2.	Calcium
3.	Interleukin-1 (Interleukin 1)
4.	elcatonin
5.	1-hydroxycholecalciferol (alfacalcidol)
6.	Alendronate (Alendronate Sodium)
7.	Etidronic Acid (HEDP)
8.	Acetic Acid (Vinegar)
9.	Prednisolone (Predate)
10.	salmon calcitonin (Calcimar)

Related Therapies and Procedures

1.	Injections
2.	Self Administration (Administration, Self)
3.	Ovariectomy (Oophorectomy)
4.	Renal Dialysis (Hemodialysis)
5.	Hormone Replacement Therapy (Therapy, Hormone Replacement)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>